Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug eruptions: Great imitators.

Chia-Yu Chu1

  • 1Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

Clinics in Dermatology
|June 10, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Uncovering a Dual Th17/Type 2 Transcriptomic Endotype in Psoriasis.

Journal of the American Academy of Dermatology·2026
Same author

A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence.

Dermatology and therapy·2026
Same author

Clinical and Pathological Predictors of Unfavourable Outcomes in Thin and In Situ Melanomas: A Retrospective Cohort Study from Taiwan.

Acta dermato-venereologica·2026
Same author

Reduced conjunctival goblet cells and altered tear film stability predispose atopic dermatitis patients to develop dupilumab-associated ocular surface disease and show a Th1/innate immune response in tear fluid.

Allergology international : official journal of the Japanese Society of Allergology·2026
Same author

Darier disease-A review highlighting new insights from the Darier Disease International Task Force.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions.

The Journal of allergy and clinical immunology·2026
Same journal

Letter to the editor in reply to "Ethics of Rising Trends in Dermatology Publications Using Large-Scale Databases".

Clinics in dermatology·2026
Same journal

Ethics of suggesting image-guided superficial radiation therapy on the pathology report.

Clinics in dermatology·2026
Same journal

Tanorexia: The Psychodermatology of Compulsive Tanning.

Clinics in dermatology·2026
Same journal

Ear manifestations of connective tissue diseases: A dermatologic, histopathologic, and clinicopathologic review.

Clinics in dermatology·2026
Same journal

Discovery of an intravenous drug injection site: A meticulous cutaneous examination provides the forensic dermatologic clue to a diagnosis of homicide.

Clinics in dermatology·2026
Same journal

Sherlock Holmes and the mystery of the deadly diet.

Clinics in dermatology·2026
See all related articles

Drug eruptions can mimic other skin conditions, posing diagnostic challenges. Recognizing these drug-induced skin diseases and dermatosis-like drug eruptions is crucial for accurate diagnosis and patient care.

Area of Science:

  • Dermatology
  • Pharmacology

Background:

  • Drug eruptions are common and can present diagnostic challenges.
  • Pharmacologic agents can induce skin changes through various mechanisms.
  • These eruptions can mimic specific dermatoses or present with distinct features.

Purpose of the Study:

  • To highlight the diagnostic complexities of drug eruptions.
  • To differentiate between drug-induced skin diseases and dermatosis-like drug eruptions.
  • To emphasize the importance of identifying causative agents.

Main Methods:

  • Review of clinical presentations and pathophysiologic mechanisms of drug eruptions.
  • Classification of drug eruptions into distinct categories.
  • Analysis of diagnostic pitfalls in clinical practice.

Related Experiment Videos

Main Results:

  • Drug eruptions are classified as drug-induced skin diseases or dermatosis-like drug eruptions.
  • Both types can mimic other dermatologic conditions.
  • Misdiagnosis can result from unrecognized causative agents.

Conclusions:

  • Drug eruptions are significant diagnostic challenges in dermatology.
  • Accurate identification of drug-induced skin conditions is essential.
  • Awareness of these 'great masqueraders' can improve patient outcomes.